Twist Bioscience Corporation
TWST
$47.66
-$1.98-3.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 197.95M | 232.43M | 250.80M | 257.15M | 270.83M |
| Total Receivables | 50.06M | 57.02M | 51.05M | 51.15M | 39.32M |
| Inventory | 32.92M | 28.31M | 25.94M | 20.86M | 23.52M |
| Prepaid Expenses | 22.95M | 15.20M | 11.99M | 9.29M | 11.65M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 303.88M | 332.97M | 339.78M | 338.44M | 345.31M |
|
|
|||||
| Total Current Assets | 303.88M | 332.97M | 339.78M | 338.44M | 345.31M |
| Net Property, Plant & Equipment | 177.39M | 151.66M | 147.20M | 151.21M | 157.14M |
| Long-term Investments | 82.20M | 82.20M | 82.20M | 85.81M | 85.81M |
| Goodwill | 82.20M | 82.20M | 82.20M | 85.81M | 85.81M |
| Total Other Intangibles | 13.16M | 13.43M | 13.69M | 13.95M | 14.22M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.12M | 7.28M | 6.41M | 6.20M | 6.10M |
| Total Assets | 638.09M | 641.86M | 643.61M | 595.62M | 608.58M |
|
|
|||||
| Total Accounts Payable | 12.49M | 11.09M | 11.99M | 8.06M | 7.50M |
| Total Accrued Expenses | 42.24M | 54.34M | 48.51M | 44.49M | 41.87M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.24M | 13.82M | 15.50M | 15.22M | 15.03M |
| Total Finance Division Other Current Liabilities | 13.47M | 12.15M | 11.08M | 7.21M | 5.24M |
| Total Other Current Liabilities | 13.47M | 12.15M | 11.08M | 7.21M | 5.24M |
| Total Current Liabilities | 80.44M | 91.41M | 87.07M | 74.98M | 69.65M |
|
|
|||||
| Total Current Liabilities | 80.44M | 91.41M | 87.07M | 74.98M | 69.65M |
| Long-Term Debt | 15.00M | 15.00M | 15.00M | 15.00M | 15.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 85.81M | 61.75M | 62.65M | 65.08M | 67.59M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 741.00K | 747.00K | 688.00K | 451.00K | 407.00K |
| Total Liabilities | 181.99M | 168.90M | 165.41M | 155.51M | 152.64M |
|
|
|||||
| Common Stock & APIC | 1.81B | 1.79B | 1.77B | 1.75B | 1.73B |
| Retained Earnings | -1.35B | -1.32B | -1.29B | -1.31B | -1.27B |
| Treasury Stock & Other | -571.00K | -627.00K | -864.00K | -662.00K | -649.00K |
| Total Common Equity | 456.10M | 472.96M | 478.20M | 440.11M | 455.94M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 456.10M | 472.96M | 478.20M | 440.11M | 455.94M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 456.10M | 472.96M | 478.20M | 440.11M | 455.94M |
|
|
|||||